Insulin resistance is central to the burden of diabetes

Diabetes/Metabolism Reviews

Volumn 13, Issue 2, 1997, Pages 81-86

  Ferrannini, Ele ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE;

EID: 0030855202     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199706)13:2<81::AID-DMR184>3.0.CO;2-M     Document Type: Review

References (27)

1. World Health Organization: Diabetes Mellitus: report of a WHO Study Group. Technical Report Series 727. WHO, Geneva, 1985.
2. De Fronzo RA: The triumvirate: β-cell, muscle, liver: collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
3. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994.
4. Lillioja S, Mott DM, Zawadzki K, Young AA, Abbott GH, Knowler WC, Bennett PH, Moll P, and Bogardus C: In vivo insulin action is a familial characteristic in non-diabetic Pima Indians. Diabetes 36: 1329-1335, 1987.
5. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, and Bogardus C: Impaired glucose tolerance as a disorder of insulin action. N Engl J Med 318: 1217-1225, 1988.
6. Groop LC, Widen E, and Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331, 1993.
7. Keen H, Jarrett RJ, and McCartney P: The ten-year follow-up of the Bedford Survey (1962-1972: glucose tolerance and diabetes. Diabetologia 22: 73-78, 1982.
8. Unger RH, and Grundy S: Hyperglycaemia as an inducer as well as a consequence of impaired islet function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-125, 1985.
9. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13: 415-431, 1992.
10. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, and Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet i: 1356-1359, 1989.
11. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, and Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329: 1988-1992, 1993.
12. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, and Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body-fat distribution. Diabetes 39: 283-288, 1990.
13. Eriksson KF, and Lindgärde F: Poor physical fitness and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39: 573-579, 1996.
14. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, and Stern MP: Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes 41: 715-722, 1992.
15. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, and Fuchs Z: Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 807-817, 1985.
16. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, and Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl JMed 320: 702-706, 1989.
17. Orchard TJ, Becker DJ, Bates M, Kuller LH, and Drash AL: Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326-337, 1983.
18. Haffner SM, Fong D, Hazuda HP, Pugh JA, and Patterson JK: Hyperinsulinaemia, upper body adiposity, and cardiovascular risk in non-diabetics. Metabolism 37: 338-345, 1988.
19. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
20. Wingard DL, and Barrett-Connor E: Heart disease and diabetes. In Diabetes in America, 2nd ed. NIH publication 95-11468, 1995, pp. 429-448.
21. Pyörälä K, Savolainen E, Kaukola S, and Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during a 9 1/2-year follow-up of Helsinki policemen study population. Acta Med Scand (Suppl.) 701: 38-52, 1985.
22. Paolisso G, Gambardella A, Galzerano D, D'Amore A, Balbi V, Varricchio M, and D'Onofrio F: Metabolic features of patients with and without coronary heart disease but with a super-imposable cluster of cardiovascular risk factors. Coronary Artery Dis 4: 1085-1091, 1993.
23. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945-947, 1994.
24. Reaven GM, and Laws A: Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 37: 948-952, 1994.
25. Stern MP: The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 37: 956-958, 1994.
26. Hughes TA, Gwynne JT, Switzer BR, Herbst C, and White G: Effect of calorie restriction and weight loss on glycemia control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med 77: 7-17, 1984.
27. Manson JE, and Spelsberg A: Primary prevention of non-insulin-dependent diabetes mellitus. Am J Prev Med 10: 172-184, 1994.